In today’s recent session, 6,719,112 shares of the Caladrius Biosciences, Inc.(NASDAQ:CLBS) have been traded, and its beta is 1.23. Most recently the company’s share price was $2.03, and it changed around -$0.2 or -0.09% from the last close, which brings the market valuation of the company to $62.64 Million. CLBS at last check was trading at a discount to its 52-week high of $4.89, offering almost -140.89% off that amount. The share price’s 52-week low was $1.05, which indicates that the recent value has risen by an impressive 48.28% since then. We note from Caladrius Biosciences, Inc.’s average daily trading volume that its 10-day average is 11.41 Million shares, with the 3-month average coming to 4.89 Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Caladrius Biosciences, Inc. stock received a consensus recommendation rating of Overweight, based on a mean score of 2.3. If we narrow it down even further, the data shows that none out of 2 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, 1 recommended CLBS as a Hold, whereas 1 deemed it a Buy, and no one rated it as Underweight. Caladrius Biosciences, Inc. is expected to report earnings per share of -$0.25 for the current quarter.

Caladrius Biosciences, Inc. (NASDAQ:CLBS): Trading Information Today

Although CLBS has been showing red trend so far today with a performance of -8.97% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of $2.50- on Wednesday, Feb 17 increased the stock’s daily price by 19.96%. The company’s shares are currently up 0.4% year-to-date, but still down -0.1799 over the last five days. On the other hand, Caladrius Biosciences, Inc. (NASDAQ:CLBS) is -0.16% down in the 30-day period. We can see from the shorts that 2.93 Million shares have been sold at a short interest cover period of 0.6 day(s).

The consensus price target as assigned by Wall Street analysts is $14, which translates to bears needing to increase their stock price by 589.66% from its current value. Analyst projections state that CLBS is forecast to be at a low of $14 and a high of $14. In order for the stock price to hit the forecast high, the stock would need to surge +589.66% from its current level, while the stock would need to crash 589.66% from its current level to reach the projected low.

Caladrius Biosciences, Inc. (CLBS) projections and forecasts

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 35.5%. Caladrius Biosciences, Inc. earnings are expected to decrease by -12.4% in 2021, but the outlook is negative 0% per year for the next five years.

Caladrius Biosciences, Inc. (NASDAQ:CLBS)’s Biggest Investors

Upon looking at major shareholders, it appears that insiders hold 12.18% of Caladrius Biosciences, Inc. shares, and 19.23% of them are in the hands of institutional investors. The stock currently has a share float of 21.9%. Caladrius Biosciences, Inc. stock is held by 38 institutions, with Renaissance Technologies, LLC being the largest institutional investor. By Dec 30, 2020, it held 3.17% of the shares, which is about 1.05 Million shares worth $1.5 Million.

Vanguard Group, Inc. (The), with 1.04% or 342.61 Thousand shares worth $489.93 Thousand as of Dec 30, 2020, holds the second largest percentage of outstanding shares.

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.


Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 29, 2020. The former held 204746 shares worth $368.54 Thousand, making up 0.62% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 94.92 Thousand shares worth around $170.85 Thousand, which represents about 0.29% of the total shares outstanding.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free


Please enter your comment!
Please enter your name here